Patients with relapsed/refractory chronic lymphocytic leukaemia may benefit from inclusion in clinical trials irrespective of the therapy received: a case-control retrospective analsysis

Detalles Bibliográficos
Autores principales: Esteban, D, Tovar, N, Jiménez, R, Santacruz, R, Baumann, T, Pastor, MaC, de la Riva, A, Carrera, E, Chaves, S, Royo, C, Navarro, A, Rodríguez, S, Ayuso, C, Riu, G, Creus, N, Gómez, B, Giné, E, López-Guillermo, A, Delgado, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635190/
https://www.ncbi.nlm.nih.gov/pubmed/26430727
http://dx.doi.org/10.1038/bcj.2015.78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635190/
https://www.ncbi.nlm.nih.gov/pubmed/26430727
http://dx.doi.org/10.1038/bcj.2015.78

Ejemplares similares